Phase II

Phase II of clinical research involves testing a new drug or treatment on a larger group of people to evaluate its effectiveness and safety. This phase aims to determine whether the treatment works as intended and to identify any side effects or risks. Typically involving dozens to hundreds of participants, it helps researchers fine-tune dosing and assess whether further testing is justified. Phase II is crucial for deciding if the treatment should move forward to larger, more definitive trials.